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An expanded hexanucleotide repeat in the C9orf72 gene is the most common genetic cause of amyo-
trophic lateral sclerosis and frontotemporal dementia (C9ALS/FTD). Although 0e30 hexanucleotide re-
peats are present in the general population, expansions >500 repeats are associated with C9ALS/FTD.
Large C9ALS/FTD expansions share a common haplotype and whether these expansions derive from a
single founder or occur more frequently on a predisposing haplotype is yet to be determined and is
relevant to disease pathomechanisms. Furthermore, although cases carrying 50e200 repeats have been
described, their role and the pathogenic threshold of the expansions remain to be identiﬁed and carry
importance for diagnostics and genetic counseling. We present clinical and genetic data from a UK ALS
cohort and report the detailed molecular study of an atypical somatically unstable expansion of 90 re-
peats. Our results across different tissues provide evidence for the pathogenicity of this repeat number by
showing they can somatically expand in the central nervous system to the well characterized pathogenic
range. Our results support the occurrence of multiple expansion events for C9ALS/FTD.
 2015 The Authors. Published by Elsevier Inc. All rights reserved.e CC BY license (http://
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Expansions of aGGGGCChexanucleotide repeat in theﬁrst intron
and/or promoter region of C9orf72 are the most frequent known
monogenic cause of amyotrophic lateral sclerosis (ALS) and fronto-
temporal dementia (FTD) in populations of European descent
(DeJesus-Hernandez et al., 2011; Gijselinck et al., 2012; Majounie
et al., 2012; Renton et al., 2011). Repeats ranging in size from 0 to
30 are found in the general population, whereas pathogenic ex-
pansions range between 500 and 4500 repeats, with considerable
somatic instability (Beck et al., 2013;DeJesus-Hernandez et al., 2011;ts reserved.
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Fig. 1. Case 61776 shows a somatically unstable repeat. (A) Map of the C9orf72 locus
illustrating the probe and the restriction sites used for single-copy 1-kb probe
Southern hybridization. The site of the hexanucleotide expansion is indicated with a
circle. (B) Southern hybridization performed on a typical bimodal C9orf72 repeat
expansion (Pos) and case 61776 with the following restriction digestions: EcoRI/BamHI
(E/B), Bsu36I (Bs), and EcoRI (E). The somatic mosaicism in 61776 is evident in the E/B
digest lane (marked with *).
Table 1
Summary of clinical features of the general cohort and C9orf72 expansion positive
individuals
C9orf72 expansion
negative patientsa
(n ¼ 422)
C9orf72 expansion
positive patientsb
(n ¼ 30)
Male:female 1.55 2.00
Age at onset  SD (y) 59.3  12.5 54.6  8.1
Bulbar onset (%) 27.3 26.1
Positive family history (%) 3.8 30.0
Key: SD, standard deviation.
a Site of onset and age of onset missing for 81 patients and gender missing for 62
patients.
b Site of onset and gender missing for 7 patients and gender missing for 3 patients.
P. Fratta et al. / Neurobiology of Aging 36 (2015) 546.e1e546.e7546.e2van Blitterswijk et al., 2013b). The ﬁnding of a conserved haplotype
spanning approximately 200 kb around pathogenic expansionsmay
result from either a common founder, or a “risk” haplotype predis-
posing to expansion (Beck et al., 2013; Majounie et al., 2012; Mok
et al., 2012; Pliner et al., 2014). How the C9orf72 expansion leads to
disease is as yet unknown, proposed mechanisms include the
following: (1) loss of C9orf72 function; (2) RNA toxicity associated
with the presence of nuclear repeat expansion RNA foci; and (3)
protein toxicity caused by dipeptide repeats originating from the
translation of the repeat expansion (Ling et al., 2013).
We present genetic and clinical data from C9orf72 screening in a
UK ALS cohort. We conﬁrm the clinical features previously associ-
ated with C9orf72 expansions and report an atypical expansion
with approximately 90 repeats in blood which shows somatic
instability within and between tissues. Our analysis of multiple
tissues shows the repeat signiﬁcantly expanded in the central
nervous system (CNS) to over 3000 hexanucleotides.
Our data, together with recently reported cases, strongly sup-
port the hypothesis that C9orf72 repeat expansions occur in
different individuals in the context of the permissive risk haplotype
(Dols-Icardo et al., 2014; Van Blitterswijk et al., 2013b). This ﬁnding
sheds light on the origins of the C9orf72 repeat expansion and has
important implications for pathomechanisms of C9orf72 ALS/FTD,
diagnostic testing, and genetic counseling for C9orf72 expansions.
2. Methods
We screened a cohort of 452 ALS patients who had not been
screened for other genetic causes of ALS, from University College
London Partners Motor Neuron Disease clinics (London, UK). Pa-
tients gave written consent, and the project was approved by the
local ethical review committee. DNA was extracted from blood and
ﬂash-frozen tissues using standard techniques.
Fibroblasts were generated from a 3-mm skin punch biopsy
taken under local anesthetic following informed consent. Biopsies
were dissected into 1 mm pieces and cultured at 37 C, 5% CO2 in
DMEM, 10% FBS, 1% L-Glutamine, 50U/mL penicillin, and 50 mg/mL
streptomycin until ﬁbroblasts were seen to grow out from the ex-
plants. Media changes were performed every 3 days. When ﬁbro-
blasts reached conﬂuency, they were detached from culture dishes
using TrypleE (Invitrogen) and transferred to larger culture vessels
for further expansion. Cells (1  107) were used for genomic DNA
extraction using the standard techniques.
Repeat-primedpolymerase chain reactionexpansion screeningand
single-nucleotide polymorphism (SNP) genotyping was performed on
blood-derivedDNAaspreviouslydescribed (Becket al., 2013;Majounie
et al., 2012). Genetic screening data for 350 patients were previously
reported (Beck et al., 2013). Two Southern hybridization methods for
expansion sizing were performed using: (1) an oligonucleotide probe
consistingof5GGGGCCrepeats (Becketal., 2013);or (2) a single-copy1
kb probe (Fratta et al., 2013) that anneals adjacent to the repeat (see
Supplementary Table 1 for PCR-primer sequences used to derive the
single-copy probe). Three different restriction enzymedigestionswere
used in the single-copy probe method to produce “normal” bands of
different sizes: EcoRI/BamHI double digest: 2.4 kb; BsU36I: 6.2 kb;
EcoRI: 8 kb (Fig. 1A); the 6.2 kb and 8 kb bands compress the large
somatic smears in expansion-positives for unambiguous detection,
whereas the 2.4-kb band allows accurate sizing.
Case 61776 was donated to the NeuroResource tissue bank, UCL
Institute of Neurology. Routine neuropathologic assessment was
carried out in the Queen Square Brain Bank for Neurological Dis-
orders (Lashley et al., 2011). Formalin-ﬁxed and parafﬁn-embedded
tissue sections (7microns thick) were immunostained as previously
described using commercially available antibodies to the following
proteins: TDP-43 (Abnova, Taipei City, Taiwan; 1:800), p62 (BDTransduction Laboratories, Oxford, UK; 1:200), ubiquitin (Dako,
Ely, UK; 1:200), a-synuclein (Vector, Peterborough, UK; 1:50), Ab
(Dako; 1:100), tau (AT8 clone; Autogen Bioclear, Wiltshire, UK;
1:600), CD68 (Dako; 1:150), and GFAP (Dako; 1:1000) as previously
described (Lashley et al., 2011). Sections were also immunostained
with novel antibodies able to detect each of the proteins generated
by non-ATG dependent translation of the noncoding repeat
expansion. Antibodies, made in rabbits by Biogenes (Germany),
were generated against (Gly-Ala)7, (Gly-Pro)7, (Gly-Arg)7, (Pro-Arg)7,
or (Pro-Ala)7 peptides.
Fluorescence in situ hybridization was performed with 20-O-
methyl RNA probes (Integrated DNA Technologies): (GGCCCC)4 for
sense and (GGGGCC)4 for antisense RNA foci, 50 labeled with Cy3 or
Alexa488, respectively. In parallel with staining with NeuN (ABN78,
Millipore; 1:250) to identify neurons was performed as previously
described (Mizielinska et al., 2013).
3. Results
3.1. Clinical features and C9orf72 screening of a UK ALS cohort
We screened C9orf72 hexanucleotide repeats in 452 ALS patient
blood-derived DNA samples using repeat-primed polymerase chain
Fig. 2. Immunohistochemical analysis of case 61776. Small p62-positive “star-like” inclusions were present in the granule cells of the dentate fascia (A) and the cerebellar cortex (B).
Larger p62-positive inclusions were seen in the CA4 subregion of the hippocampus and also contained intranuclear inclusions (C). TDP-43-positive oligodendroglial inclusions were
seen in the striatum (D) and substania nigra (F). TDP-43-positive neuronal cytoplasmic inclusions were present in the 12th nerve nucleus (E) and spinal cord (G). The “star-like” p62-
positive inclusions were also positive with anti-glycine proline (H) and anti-glycine arginine dipeptide antibodies (I). Bar represents 50 mm in A and B; 20 mm in E, G, H, and I; and
10 mm in C, D, and F.
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(6.6%), hereafter referred to as C9þ individuals. The mean age at
onset of C9þ cases was 54.6 years compared with 59.3 years in
noncarriers. Site of disease onset was bulbar in 26% of C9þ cases
compared with 27% in noncarriers (Table 1).3.2. Sizing of C9orf72 repeat reveals one exception to very large
expansions
Southern hybridizations were performed on blood DNA from 27
C9þ cases (19 previously reported) (Beck et al., 2013; see
Supplementary Fig. 1 for details on the additional 8) and conﬁrmed
the presence of somatically unstable expanded repeats with sizes
between 1100 and 4200. One exception was case 61776 which
showed a doublet indicating a small expansion of the C9orf72
repeat (Beck et al., 2013). To better discriminate the size of the
expanded repeat, we performed single-copy probe Southern blot-
ting and established that this individual carried an expansion of
approximately 90 repeats in blood. The EcoRI/BamHI double digest,electrophoresed as a smear indicating somatic instability (70e120
repeats) (Fig. 1B).
3.3. Case 61776 shows typical C9orf72 molecular and
histopathologic features in postmortem brain
The clinical features of case 61776, outlined in Supplementary
Material were typical of ALS, with no family history of the dis-
ease, bulbar onset at 57 years, and a 6-year disease course before
death.
Postmortem neuropathologic analysis revealed mild frontal at-
rophy and a discoloration of the anterior horn in the spinal cord.
Numerous p62-positive and TDP-43 negative star-like neuronal
cytoplasmic inclusions were seen in the granule cells of the dentate
fascia, hippocampal subregions, and cerebellar cortex (Fig. 2A and
B). These were shown to contain the dipeptide proteins (Fig. 2H and
I). An occasional TDP-43-positive inclusion was seen in oligoden-
drocytes of the pencil ﬁbers of the striatum and substantia nigra
(Fig. 2D and F). The neurons of the XII cranial nerve nucleus were
depleted with a single TDP-43 neuronal cytoplasmic inclusion seen
P. Fratta et al. / Neurobiology of Aging 36 (2015) 546.e1e546.e7546.e4(Fig. 2E and G). Thoracic spinal cord showed severe depletion of the
anterior horn neurons together with degeneration of both the
crossed and uncrossed corticospinal tracts. Occasional TDP-43-
positive cytoplasmic inclusions were observed in surviving motor
neurons along with ﬁne neuropil threads and occasional oligo-
dendroglial cells with ﬁne ﬁlamentous intracytoplasmic inclusions.
RNA foci containing sense and antisense C9orf72 expansion
transcripts are a characteristic feature of C9orf72 ALS/FTD. To
investigate the presence of RNA foci in this case, ﬂuorescence in situ
hybridization was performed. We detected abundant sense and
antisense foci in the frontal cortex (Fig. 3) and also in the hippo-
campus, cerebellum, and spinal cord (data not shown).
3.4. An expansion of the C9orf72 hexanucleotide repeat has
occurred in the CNS
We performed Southern blots on DNA derived from postmortem
ﬂash-frozen CNS samples from case 61,776. Frontal cortex, cere-
bellum, and spinal cord-derived DNA showed very large C9orf72
repeat expansions (approximately 950e3000þ repeats), not
differing from typical C9orf72 cases, with the exception of the
presence in the spinal cord DNA of a band representing the 90
repeat expansion together with the larger repeat (Fig. 4A).
In the absence of parental DNA, to answer whether the hex-
anucleotide repeat had expanded speciﬁcally in the CNS, or
whether there had been a retraction in a regenerating tissue such as
blood, where a selective pressure can be envisaged, we also
analyzed the C9orf72 repeat size in tissues and cell types withFig. 3. Fluorescence in situ hybridization of case 61776. RNA foci containing sense (A and B)
Neurons are identiﬁed by NeuN staining in green (B) and in red (D). Scale bar ¼ 5 mm.diverse embryological derivations, including dura mater (meso-
derm or a proposed dual mesoderm-ectoderm origin) (Adeeb et al.,
2012; Kaplan et al., 2005), cauda equina (ectoderm), and skin-
derived ﬁbroblasts (mesoderm) (Fig. 4A and B). All samples
showed the presence of the smaller 90 repeat expansion similar to
that in blood (mesoderm). These results suggest the repeat has
expanded in size in the developmental lineage after the differen-
tiation between central and peripheral nervous system and making
the possibility of a retraction to the same size in multiple tissues
less likely.
3.5. Assessing the threshold for somatic repeat expansion instability
Previous reports have indicated that 20e30 hexanucleotide
repeat expansions, commonly referred to as “intermediate” repeats,
play a pathogenic role (Gómez-Tortosa et al., 2013). To assess if
similar somatic instability occurs in these repeats, we performed
Southern blotting on 8 samples with 20e27 repeat expansions and
showed no detectable instability in this size range (Fig. 4C).
3.6. A permissive haplotype and multiple expansion events
We then assessed if case 61776 carried the risk haplotype found
to associate with all known cases of C9orf72 ALS/FTD and per-
formed genetic analysis of 36 of the 42 SNPs that deﬁne this
“Finnish risk” haplotype (Majounie et al., 2012). Results showed
that case 61776 carried the risk allele on a consecutive stretch of 22
SNPs spanning 105 kb upstream to 26 kb downstream of theand antisense (C and D) C9orf72 expansion transcripts are present in the frontal cortex.
Fig. 4. Single-copy probe Southern blotting of case 61776. (A) Southern blots of DNA from various tissues, DNA digested with BsU36I. The expansion to a large repeat has occurred in
the frontal cortex, cerebellum, and spinal cord. (B) Blood and ﬁbroblast DNA double-digested with BamHI/EcoRI. The ﬁbroblasts only possess the 90 repeat allele and not the large
expansion. (C) Southern blots following BamHI/EcoRI digestions performed on individuals with repeat sizes of, in order on the blot, 2þ20, 2þ22, 2þ24, 5þ26, 10þ25, 2þ23, 2þ23,
and 5þ27 repeats (sized by PCR), and 2 independent blood DNA extractions from case 61776 (mosaic band marked with *) whose nonexpanded allele has 5 repeats. No mosaicism
was shown in the cases with 20e27 repeats. The position of the bands did not reﬂect their size relative to each other in all cases: the electrophoresis of the bands where more DNA
was loaded was retarded in the agarose gel. Abbreviations: Neg, negative control; PCR, polymerase chain reaction; Pos, positive control.
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other C9orf72 positive cases.
3.7. Atypical C9orf72 repeat expansions occur at low frequency in
blood
To estimate the frequency of atypical repeat expansions, we
reviewed all C9orf72 Southern blotting data published until the
beginning of March 2014. Of 345 C9þ ALS/FTD probands (where
expansion size was investigated by Southern blotting), 13 showed
atypical expansions of 50e200 repeats (3.8%), including 2 cases
where the 50e200 repeat allele occurred in conjunctionwith a large
expansion (Buchman et al., 2013; Waite et al., 2014). A number of
these blots were performed on DNA derived from lymphoblastoid
cell lines which are known to poorly represent the range of repeats
in vivo (Beck et al., 2013; Hübers et al., 2014). If only Southern blots
performed on blood DNA are considered, 6/195 expansions fall
within the 50e200 repeat range (3.1%) (Supplementary Table 3).
4. Discussion
We present clinical features and C9orf72 expansion frequency
and sizing data for a cohort of 452 UK ALS patients. In accordance
with previous reports, the age at onset in the C9þ group is younger
than C9 cases (Majounie et al., 2012). In our cohort, bulbar onset
prevalence was not increased in C9þ cases. The frequency of
C9orf72 repeat expansions has been found to vary between
different geographical regions (Pliner et al., 2014; Woollacott and
Mead, 2014); in our cohort, the frequency (w7%) is similar to that
reported in previous UK studies (Cooper-Knock et al., 2012).
Although the presence of C9orf72 repeat expansion has been
tested in numerous studies, only a minority have used Southern
blotting to size the hexanucleotide expansion (Beck et al., 2013;
Buchman et al., 2013; DeJesus-Hernandez et al., 2011; Dobson-
Stone et al., 2013; Dols-Icardo et al., 2014; Fratta et al., 2013; Harmset al., 2013; Hensman Moss et al., 2014; Hübers et al., 2014, p. 72;
Ishiura et al., 2012; Mann et al., 2013; Meisler et al., 2013; Murray
et al., 2013; Takada et al., 2012; Van Blitterswijk et al., 2013a,
2013b; Waite et al., 2014). Overall, these have shown that in DNA
extracted from the most commonly analyzed tissues, such as blood,
cerebellum, and frontal cortex,most of the expansions range between
several hundred to several thousand repeats. The largest smears were
typically observed in blood, and a larger, tighter band commonly
observed in frontal cortex, compared with a smaller, more diffuse
smear in the cerebellum (Beck et al., 2013; Van Blitterswijk et al.,
2013b). In rare cases, expansions of approximately 50e200 repeats
have been reported in blood DNA (Buchman et al., 2013; Dobson-
Stone et al., 2013; Dols-Icardo et al., 2014; Van Blitterswijk et al.,
2013b). The pathogenicity of such size repeats and the corresponding
repeat size in CNS tissues in some of these cases remains to be
determined.
Our analysis of the C9orf72 repeat expansion size in blood
conﬁrms the presence of several hundred to several thousand
repeats in most of the cases, but we also describe a single case
carrying approximately 90 repeats in blood and other tissues. The
postmortem analysis on this case shows the typical C9orf72 pa-
thology pattern and interestingly, Southern blotting of frontal
cortex, cerebellum, and spinal cord regions showed an expansion
much larger than in blood and in the typical range of C9orf72
cases.
Our Southern blot analysis performed on cells and tissues from
diverse embryological origins strongly suggests that an expansion
from 90 repeats to 950e3000þ repeats occurred in the CNS.
Indeed, the large expanded repeat is present only in brain and
spinal cord, whereas the 90 repeat expansion is present both in
ectodermally derived cauda equina and in more “distantly-
related” tissues such as ﬁbroblasts, blood and dura mater that
originate from the mesoderm and mesoderm and/or ectoderm.
These ﬁndings are consistent with those recently published by
Van Blitterswijk et al. (2013b) who presented a case (P20) with a
P. Fratta et al. / Neurobiology of Aging 36 (2015) 546.e1e546.e7546.e6small expansion in several non-CNS tissues and large expansions
in CNS tissue.
In both cases, the “small” expanded alleles are very similar in
size among tissues, making the possibility of a retraction of the very
large expansion to one of approximately 90 repeats unlikely. Indeed
our ﬁndings demonstrate this would involve multiple retraction
events (e.g., in the mesoderm and ectodermal peripheral nervous
system progenitors) and, further, all retraction events would need
to lead to the same ﬁnal size.
Dols-Icardo et al. (2014) have described a family where 3
brothers carry repeats ranging from 116 to 148 in blood, with
offspring of 2 of the brothers inheriting repeats of 120 and 1401
repeats. This ﬁnding brings further support to the “multiple origin”
hypothesis of C9orf72 large expansions.
The presence of the typical Finnish haplotype in the case here
described supports the possibility that a permissive allele, pre-
disposes to the hexanucleotide repeat expansion.
Another possible explanation, compatible with the single
founder hypothesis, is that the original expansion occurred to a size
of approximately 90 repeats, which expanded further in multiple
cases. Given the instability of such repeats within the individual
described here, and between generations (Dols-Icardo et al., 2014),
this appears unlikely.
Whether retractions may also occur in C9orf72 cases remains a
possibility. Van Blitterswijk et al. (2013b) have reported 2 cases in
which multiple tissues have large expansions with the exception of a
smaller band in either skeletal muscle (P14) or testes (P25). In these
cases, single retraction events in those tissues may be possible.
The pathogenic threshold of the C9orf72 expansion remains to
be determined. The ﬁndings reported here underline the necessity
to study both peripheral and CNS tissues to identify this. Expan-
sions ranging from 20 to 22 repeats have been associated with FTD
(Gómez-Tortosa et al., 2013), but further segregation data and
screening of large numbers of patients and controls are needed to
clarify their signiﬁcance.Whether these repeats expand somatically
also remains to be addressed, but it is important to note that alleles
of 20e27 repeats, in contrast to case 61776, did not show somatic
instability in our study. The presence of somatic instability in blood
does not offer direct evidence of pathogenicity, but is an important
feature to consider, because inmany neurologic disorders caused by
nucleotide repeat expansions, pathogenic expansions are charac-
terized by somatic instability, often with greater instability in tis-
sues directly related to disease (Brouwer et al., 2009; Kennedy et al.,
2003).
In diagnostic testing for Huntington disease, spinocerebellar
ataxias types 1, 2, 3, 7, Friedreich ataxia, dentatorubral-
pallidoluysian atrophy, and X-linked spinal bulbar muscular atro-
phy, our laboratory has screened over 40,000 alleles and observed
somatic instability in DNA extracted from blood in all pathogenic
repeats but none from alleles with repeats in the nonpathogenic
range. Taken together, these data suggest the threshold for insta-
bility may lie between >30 and 90 repeats.
Our review of all published C9þ cases underlines the fact that
atypical expansions detected in blood represent approximately 3.1%
of cases. Genetic counseling for these patients is currently chal-
lenging, because CNS tissues have not been examined in all pub-
lished cases and the pathogenic repeat threshold and the likelihood
of expansion in the brain speciﬁcally is unknown. Future studies
addressing further aspects of the hexanucleotide expansions, such
as the methylation state of the repeat itself and surrounding re-
gions, may also contribute to the discrimination between patho-
genic and nonpathogenic expansions (Xi et al., 2013).
We provide additional evidence that the C9orf72 expansion has
occurred on multiple occasions on a permissive haplotype. That
somatic instability may play a fundamental role in certain caseshighlights the importance the understanding of this mechanism
may have and may point to possible therapeutic strategies.
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